Novartis AG (NVSEF)

96.00 -0.87 (-0.90%) At close: 03:43PM EST

Novartis AG

Lichtstrasse 35
Basel 4056
Switzerland
41 61 324 1111
https://www.novartis.com

Sector(s): Healthcare
Industry: Drug Manufacturers - General
Full Time Employees: 101,703

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Vasant Narasimhan	Chief Executive Officer	5.85M	N/A	1976
Mr. Harry Kirsch	Chief Financial Officer	2.96M	N/A	1965
Dr. Steffen Lang Ph.D.	President of Operations	2.43M	N/A	1967
Dr. Klaus Moosmayer Ph.D.	Chief Ethics, Risk & Compliance Officer	1.61M	N/A	1968
Ms. Karen L. Hale	Chief Legal Officer	2.44M	N/A	1968
Dr. Robert Kowalski Pharm.D.	Chief People & Organization Officer	2.18M	N/A	1968
Mr. Victor Bulto	President of US	2.39M	N/A	N/A
Dr. Shreeram Aradhye M.D.	President of Global Drug Development & Chief Medical Officer	2.38M	N/A	1963
Mr. Aharon Gal Ph.D.	Chief Strategy & Growth Officer	6.54M	N/A	N/A
Dr. Fiona H. Marshall Ph.D.	President of BioMedical Research	5.3M	N/A	1964

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.

Corporate Governance

Novartis AG’s ISS Governance QualityScore as of December 1, 2023 is 1. The pillar scores are Audit: 1; Board: 2; Shareholder Rights: 1; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.